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Abstract
Background: Arthritis and depression often co-occur; however, studies that describe patterns of depression
treatment among individuals with arthritis are scant. The purpose of the study was to examine depression
treatment patterns among individuals with osteoarthritis (OA) by predisposing, enabling, need factors, personal
health practices and external health environment.
Methods: Retrospective cross-sectional design was used. Data were obtained from 2008 and 2010 Medical
Expenditure Panel Survey (MEPS). The sample consisted of 647adults aged over 21 years with depression and OA.
Depression treatment was categorized as: 1) No treatment;2) antidepressant use only and 3) both antidepressants
and psychotherapy (combination therapy). Chi- square tests and multinomial logistic regressions were used to
describe patterns of depression treatment. All analysis was performed using Statistical Analysis Software (SAS)
version 9.3.
Results: Overall, 13.0% of the study sample reported no depression treatment, 67.8% used antidepressants only and
19.2% used combination therapy. Among individuals with OA significant subgroup differences in depression
treatment were observed. For example, African Americans were less likely to report depression treatment compared
to whites [antidepressants: AOR=0.33, 95% CI=0.21,0.51; combination therapy: AOR=0.39, 95% CI=0.23, 0.65]. Elderly
adults were more likely to receive antidepressants and less likely to receive psychotherapy as compared to younger
adults [AOR=0.53, 95% CI= 0.28,0.98]. Adults with anxiety were more likely to report depression treatment
compared to those without anxiety [antidepressants: AOR=1.53, 95% CI=1.06, 2.22; combination therapy: AOR=3.52,
95% CI=2.40, 5.15].
Conclusion: Future research needs to examine the reason for low rates of combination therapy as well as
subgroup differences in combination therapy among individuals with OA.
Keywords: Arthritis, Antidepressants, Psychotherapy, MEPS, Depression treatment
Background
Individuals with arthritis have high rates of co-occurring
depression and/or anxiety [1]. Prior studies have reported
negative impacts of depression on the quality of life of
individuals with rheumatoid arthritis (RA), osteoarthritis
(OA) and fibromyalgia [2-4]. Among individuals with
arthritis, depression is associated with increased pain,
work disability and functional decline [5-7]. While pain is
common in individuals with arthritis [8], depression can
exacerbate this problem because depression is known to
independently cause pain [9]. Similarly, pain can also lead
to depression, suggesting that the relationship between
depression and pain is bi-directional [10]. Therefore, the
management strategies for depression should take into
account both depressive symptoms and pain [11].
Antidepressants have been found to be effective in redu-
cing pain among individuals with OA and fibromyalgia
[12,13]. Although, antidepressants therapy is the major
modality of treatment for depression, it may be used to
treat both depression and pain as well for individuals with
arthritis [4,13]. For example, a randomized controlled trial
(RCT) known as Stepped Care for Affective Disorders and
Musculoskeletal Pain found that antidepressant therapy
followed by pain self-management program resulted in
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improvement in depression scores and reduction in pain
severity and disability [14].
Combination therapy (antidepressants with psychother-
apy) is also found to be effective in treating depression
[15]. American Psychiatric Association recommends com-
bination of psychotherapy and antidepressant medication
as initial treatment for individuals with moderate to severe
major depressive disorder [15]. In an RCT of 681 adults
with chronic major depressive disorder it was concluded
that a combination of nefazodone (an antidepressant) and
psychotherapy was more effective in relieving depression
compared to either form of treatment alone [16]. This
finding has also been substantiated among individuals
with arthritis. Results from an RCT performed at 18
primary care clinics - IMPACT (Improving Mood
Promoting Access to Collaborative Treatment) among
1,801 older adults with arthritis (93% with OA) and
depression, revealed that individuals who received
combination therapy (antidepressants with psychotherapy)
experienced not only a reduction of depressive symptoms
and pain but also improvements in the functional status
and quality of life compared to those who received usual
depression treatment [4].
Objective
The aforementioned studies suggest that antidepressants
and psychotherapy can provide relief from depression
and pain among individuals with OA. However, it is not
known whether findings from these clinical trials have
been translated into routine clinical practices of depres-
sion care among individuals with OA in real-world
settings. In fact, research on patterns of depression treat-
ment among various subgroups of individuals with
depression and OA is sparse. Such studies are critical for
understanding subgroup differences in depression treat-
ment as well as informing intervention efforts to promote
effective depression care. Therefore, the main objective of
this study was to examine patterns of depression treat-
ment by predisposing, enabling, need factors, personal
health practices and external health environment among
individuals with OA.
Conceptual framework
The basic framework for the study is the expanded
behavioral model on use of health services proposed by
Anderson [17]. The model posits that healthcare treat-
ment or use is affected by: (1) each individual’s unique
predisposition for using services (predisposing factors),
(2) the means available to each individual for obtaining
services (enabling factors), and (3) each individual’s level
of need (need factors). Under this model predisposing
variables (e.g. gender, age, and race), enabling variables
(e.g. marital status, education and poverty status), need
variables (e.g. health status variables and pain), personal
health practices (e.g. physical activity, obesity and
smoking) and external healthcare environment (e.g.
metro status) affect depression treatment.
Methods
Study design
Retrospective cross-sectional study design was used to
describe patterns of depression treatment among indi-
viduals with OA.
Data source
Data were obtained from two years (2008 and 2010) of
the Medical Expenditure Panel Survey (MEPS) dataset,
which is available for public use. MEPS is a large-scale
nationally representative survey of U.S. families and indi-
viduals, medical providers and employers, implemented
by the Agency for Healthcare Research and Quality
(AHRQ). MEPS contains information on medical condi-
tions and mental health conditions, healthcare use
services and medical and mental health treatment includ-
ing prescription drugs and counseling [18]. To minimize
underreporting of conditions, MEPS used extensive
probes, provided the respondents with calendars, and used
shorter recall period [18]. In addition, MEPS elicited infor-
mation on medical and mental health conditions from
medical providers. Respondents were queried whether: 1)
they had been diagnosed with specific conditions, 2) the
household members had experienced a medical event
such as emergency visit or office visit for the condition, 3)
the condition caused disability, and 4) the chronic condi-
tion bothered the respondent during a specific reference
period [19]. The medical conditions reported by the
household respondent were found to be consistent with
data from medical care providers [20].
Information on medical and mental health conditions
was collected verbatim from the household respondents.
These health conditions were then converted to be con-
sistent with the International Classification of Diseases,
9th Edition, Clinical Modification (ICD-9-CM) codes by
professional coders. These ICD-9-CM codes were then
converted by AHRQ into clinical classification codes
[21]. Medical condition files available to the researchers
contain 3-digit ICD-9-CM and clinical classification
codes. For the purpose of analysis, all health conditions
used in the paper were based on clinical classification
codes or ICD-9-CM codes unless otherwise specified.
Analytical sample
For the current study, two years of cross-sectional data
were pooled to gain an adequate sample size as
recommended by MEPS designers [22]. As MEPS follows
individuals for two years, data for 2008 and 2010 were
used rather than two consecutive years to ensure that
repeated observations from the same individual are not
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included [18]. The analytical sample consisted of adults
(n=647) with depression, aged 21 years or older, alive
during the observation year and who reported OA.
Individuals with OA were identified by an affirmative
response to a question that queried whether the respon-
dents have ever been diagnosed with arthritis or if they
had clinical classification codes indicating arthritis in
their medical conditions file. A small number of individ-
uals who used only psychotherapy for depression treat-
ment were excluded (n = 25). Individuals who reported
not having any medical expenditure during the calendar
year were also excluded.
Measures
Dependent variable: depression treatment
Any Antidepressant Use was identified from prescription
drugs file using therapeutic class codes. The MEPS
linked drug names and national drug codes to Multum-
lexicon classification scheme to classify prescription
drugs into various therapeutic classes. These therapeutic
class codes were made available to the researchers. In
the current study, antidepressants were identified from
the therapeutic class code 247. Individuals with one or
more prescriptions for antidepressants were considered
as antidepressant users.
Any Psychotherapy Use was derived from outpatient
and office-based provider visits files. These files contained
information on reasons for the visits. Individuals with at
least one visit with the stated purpose of psychotherapy or
mental health counseling were considered to receive
psychotherapy [23].
Antidepressant and psychotherapy use were combined
to represent combination therapy. Depression treatment
was categorized into 3 groups: (1) no depression treat-
ment, (2) antidepressant use only, (3) and psychotherapy
with antidepressants (combination therapy).
Independent variables
Predisposing variables consisted of gender (women, men),
race (white, African Americans, and others) and age in
years grouped into 4 categories (22–39, 40–49, 50–64, 65
and above). Enabling factors consisted of marital status
(married and not married), education (less than high
school, high school, and above high school), poverty status
(poor or near poor, middle income, and high income)
and health insurance (private, public, and uninsured).
Need variables included perceived physical and mental
health status (excellent or very good, good, and fair or
poor), functional disability (yes/no), pain (pain and no
pain), and chronic conditions such as chronic obstruct-
ive pulmonary disease (COPD), diabetes, heart disease,
and anxiety. Personal health practices included current
smoking (current smoker, and others), physical activity
(moderate to vigorous 3 times/week versus no physical
activity), and body mass index (BMI) categories (under or
normal, overweight, and obese). Metro status (metro
versus non metro) was used to represent external
healthcare environment.
Pain
Pain was included as one of the need factors because
depression treatment can often be influenced by pres-
ence of pain [11]. Antidepressants are sometimes used
to relieve pain among individuals with arthritis and
other chronic conditions [24]. Information about pain
was extracted from a question that queried the respon-
dents whether pain interfered with their normal work
outside the home and housework during the past
4 weeks. In MEPS, pain was reported on a 5-point scale:
1) Not at all, 2) A little bit, 3) Moderately, 4) Quite a bit,
and 5) extremely. For purposes of this study pain was
classified into two categories: 1) pain and 2) no pain.
Self-reported pain from MEPS has been used in
published literature to estimate cost of pain [25].
Statistical analysis
Chi-square tests were used to examine significant
subgroup differences in depression treatment among
individuals with OA. Multinomial logistic regressions
were used to examine patterns of depression treatment
by predisposing, enabling, need factors, personal health
practices and external healthcare environment. The
dependent variable consisted of: (1) no depression treat-
ment, (2) antidepressant use only, and (3) psychother-
apy with antidepressants (combination therapy). For the
dependent variable, “no depression treatment” was used
as the reference category. The parameter estimates from
the regression were transformed to adjusted odds ratios
(AORs) and their corresponding 95% confidence inter-
vals (CIs) were examined. All analyses accounted for
complex survey design of MEPS with Statistical Analysis
Software (SAS) version 9.3.
Results
Among individuals with OA and depression the majority
were women (76.0%), whites (87.2%), and older adults
above age 50 (83.1%). Nearly one-third (34.4%) were
below the 100% - 200% federal poverty line. Only 24.4%
reported excellent/very good physical health and 33.5%
reported excellent/very good mental health. Anxiety was
prevalent in 25.1% of the individuals with OA and
depression. An overwhelming majority of adults with
OA reported pain (87.2%). (Data not presented in tabu-
lar form).
Table 1 presents the weighted percent of depression
treatment categories by predisposing, enabling, need
factors, personal health practices and external health
environment. Except for few variables (gender, poverty
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Table 1 Weighted percent of depression treatment among individuals with depression and osteoarthritis: medical
expenditure panel survey, 2008 and 2010
No treatment Antidepressants only Antidepressants & psychotherapy sig
Wt. (%) Wt. (%) Wt. (%)
ALL 13.0 67.8 19.2
Predisposing factors
Gender
Female 11.9 68.1 20.0
Men 16.8 66.7 16.5
Race
White 11.1 70.9 17.9 ***
African Americans 27.8 45.1 27.1
Other race 25.2 47.0 27.8
Age groups
22-39 16.4 57.6 26.0 **
40-49 12.2 55.9 31.9
50-64 12.1 65.9 22.0
65,+ 14.2 76.2 9.6
Enabling factors
Marital status
Married 11.1 74.5 14.4 **
Not married 15.2 60.2 24.5
Education
Less than high school 17.1 67.6 15.2 **
High school 17.3 70.1 12.6
More than high school 9.6 66.3 24.1
Poverty Status
Poor 13.7 63.7 22.6
Middle income 15.1 68.3 16.7
High income 11.2 71.0 17.8
Insurance
Private 12.3 72.6 15.0 *
Public 13.8 60.5 25.6
Uninsured 16.3 56.3 27.4
Need factors
Perceived physical health
Excellent/very good 13.2 72.6 14.2 *
Good 11.3 72.7 16.0
Fair/poor 14.3 61.5 24.2
Perceived mental health
Excellent/very good 12.2 75.6 12.1 **
Good 11.9 70.3 17.8
Fair/poor 15.1 57.4 27.5
Anxiety
Anxiety 7.4 54.3 38.2 ***
No anxiety 15.0 72.3 12.8
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status, metro status, physical activity, and pain) all sub-
group differences were significant at p <0.05. For example,
a significantly higher proportion of African Americans
(27.8%) reported “No depression treatment” compared to
whites (11.1%). Only 7.4% of adults with anxiety reported
“no depression treatment” compared to those without
anxiety (15.0%).
Subgroup differences by type of treatment were also
observed. For example, a significantly lower proportion of
elderly over the age of 65 years received combination
therapy (9.6%) compared to the younger age group
22–39 years (26.0%). However, a significantly higher
proportion of elderly reported using antidepressants for
depression treatment (76.2%) compared to the younger
adults in the age group 22–39 years (57.6%). Similarly, a
higher proportion of individuals with fair/poor perceived
mental health (27.5%) received combination therapy
compared to adults with excellent/very good perceived
mental health (12.1%). Compared to those with fair/poor
perceived mental health (57.4%) a higher proportion of
adults with excellent/very good perceived mental health
(75.6%) reported using antidepressants only.
AORs and 95% CIs from multinomial logistic regres-
sion on depression treatment among individuals with
Table 1 Weighted percent of depression treatment among individuals with depression and osteoarthritis: medical
expenditure panel survey, 2008 and 2010 (Continued)
Pain
Pain 11.7 68.3 19.9
No pain at all 20.7 62.0 17.4
COPD
COPD 9.4 67.4 23.2
No COPD 14.7 67.9 17.3
Diabetes
Diabetes 8.7 72.4 18.8
No diabetes 14.4 66.3 19.3
Heart disease
Heart 10.4 74.4 15.2
No heart 14.2 65.1 20.7
Functional disability
Yes 17.3 60.5 22.2 *
No 17.9 65.3 16.9
Personal health practice factors
BMI
Under-normal weight 15.6 74.3 10.1 *
Overweight 15.3 63.5 21.2
Obese 10.7 66.8 22.5
Smoking
Current smoker 11.7 60.3 27.9 *
Other 13.2 69.5 17.2
Exercise
3 times per week 14.7 66.4 18.9
No exercise 11.9 68.7 19.4
External healthcare environment
Metro
Metro 14.4 66.9 18.7
Rural 7.3 71.4 21.2
Note: Based on 647 adults, aged 21 years older with self-reported depression and Osteoarthritis who were alive during the calendar year (2008 and 2010).
Asterisks represent significant group differences by depression treatment categories based on chi-square tests.
*** p < .001; ** .001 ≤ p < .01; * .01 ≤ p < .05.
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OA are summarized in Table 2. Among individuals with
OA, African Americans were significantly less likely to
use antidepressants as compared to whites (AOR=0.33,
95% CI=0.21, 0.51); they were also less likely to use com-
bination therapy (AOR = 0.39, 95% CI=0.23, 0.65). Individ-
uals with anxiety were more likely to use antidepressants
only and combination therapy. Individuals with anxiety
were almost 3 times (AOR = 3.52; 95% CI = 2.40, 5.15) as
likely as those without anxiety to report using combination
therapy; they were more likely to use antidepressants only
(AOR = 1.53, 95% CI = 1.06, 2.22) compared to those
without anxiety.
Elderly individuals with OA (age 65 and older) were
more likely to use antidepressants only (AOR = 2.19,
95% CI = 1.40, 3.43) compared to younger adults in the
age group 22–39 years. However, they were less likely to
receive combination therapy (AOR = 0.53, 95% CI = 0.28,
0.98) compared to younger adults. Similarly, adults with
fair or poor perceived mental health were more likely to
receive combination therapy (AOR = 1.93, 95% CI = 1.15,
3.25) compared to those with excellent or very good
perceived mental health. However, they were less likely to
receive antidepressants only (AOR = 0.64, 95% CI = 0.45,
0.92) compared to those with excellent or very good or
good perceived mental health.
Women with OA were more likely to use antidepres-
sants only as compared to men (AOR = 1.67, 95% CI =
1.28, 2.18). Significant differences were not observed be-
tween genders for combination therapy. Adults with
chronic conditions such as diabetes (AOR = 1.64, 95%
CI 1.20, 2.25) and heart disease (AOR = 1.49, 95% CI =
1.07, 2.09) were more likely to receive antidepressants
only compared to those without diabetes or heart disease.
Again, statistically significant associations were not ob-
served between combination therapy and type of chronic
conditions. Adults with obesity were more likely to receive
combination therapy (AOR = 1.51, 95% CI = 1.01, 2.25)
compared to those with underweight/normal BMI cat-
egory. However, no significant differences were observed
for antidepressants use only between BMI categories.
Discussion
The current study set out to examine patterns of de-
pression treatment among individuals with OA and
depression using a nationally representative data on
non-institutionalized civilian US population. In the
study sample of adults with OA, 13.0% did not receive
any treatment for depression and 87% reported anti-
depressant use (either alone or as combination therapy).
The rate of depression treatment found in this study
was higher than that reported elsewhere. For example, a
study that examined the patterns of depression treat-
ment trends from 1998 through 2007 among all adults
reported an antidepressant use of 75.3% in 2007 [26].
However, the results cannot be directly compared due
to differences in study population and time period.
Approximately, one in five individuals with OA and
depression used combination therapy for depression
treatment. Given the beneficial effect of combination
therapy to provide relief from depressive symptoms as
well as pain one would expect a higher percentage of
individuals with arthritis to be treated with combination
therapy. Future research needs to address the barriers to
combination therapy for depression care in this popula-
tion. However, the rate of psychotherapy use found in
this study is consistent with published literature in
which 24% individuals used psychotherapy in 2005 from
office-based psychiatrists [27]. On the contrary, another
study that analyzed national trends in outpatient psycho-
therapy found lower rates of psychotherapy use esti-
mated to be 10.5% in 2007 [28]. Rate of psychotherapy
use in the study sample may not be directly comparable
as the treatment group included both antidepressants
and psychotherapy.
While this study did not analyze the reasons for no
treatment, it is evident from other studies that cost, side
effects, severity of depression, stigma, patient-provider
relationship, lack of previous family history of depres-
sion, fear of referral to the psychiatrist are barriers to de-
pression treatment [29,30]. It is also plausible individuals
with OA may rely on alternative and complementary
therapies such as yoga that have been found to be effect-
ive in treating depression [31] and therefore, this study
may have over-estimated rate of non-treatment.
Although evidence supports the use of antidepressants
for pain among individuals with major chronic pain
conditions [24], an interesting finding in this study was
the absence of a relationship between pain and antide-
pressants use in both bivariate and multivariate models.
Absence of the relationship between pain and antidepres-
sant use needs to be interpreted with caution because of a
very small sample size of adults without pain.
The study findings with respect to racial disparities in
depression treatment among individuals with OA are
consistent with the existing literature. For example,
African Americans were less likely to receive antide-
pressants and combination therapy for depression com-
pared to whites. Existing studies have suggested that
African Americans were less likely to accept antidepres-
sants and counseling as compared to other racial/ethnic
subgroups due to socio economic status, access to care
and patient preferences [32-34].
This study found greater likelihood of antidepressants
use and lower likelihood of psychotherapy among elderly
compared to younger adults. These findings are consist-
ent with evidence from published literature that suggests
an association between increasing age and decreasing
odds of receiving psychotherapy [35,36]. As mentioned
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Table 2 Adjusted odds ratios and 95% confidence intervals from multinomial logistic regression on depression
treatment among individuals with depression and osteoarthritis: medical expenditures panel survey, 2008 and 2010
Antidepressants only Antidepressants & psychotherapy
AOR 95% CI Sig AOR 95% CI Sig
Predisposing factors
Gender
Male
Female 1.67 [1.28,2.18] *** 1.42 [0.96,2.09]
Race
White
African Americans 0.33 [0.21,0.51] *** 0.39 [0.23,0.65] ***
Other race 0.39 [0.26,0.58] *** 0.60 [0.36,0.98] *
Age
22-39
40-49 1.60 [1.09,2.34] * 1.27 [0.82,1.98]
50-64 2.24 [1.46,3.42] *** 1.43 [0.90,2.26]
65,+ 2.19 [1.40,3.43] *** 0.53 [0.28,0.98] *
Enabling factors
Marital status
Married
Not married 0.71 [0.54,0.95] * 1.01 [0.68,1.49]
Education
High school
Less than high school 0.68 [0.45,1.04] 0.39 [0.24,0.62] ***
More than high school 0.89 [0.64,1.22] 0.55 [0.36,0.84] **
Poverty status
High income
Poor 0.86 [0.58,1.28] 0.88 [0.55,1.42]
Middle income 0.76 [0.53,1.10] 0.52 [0.32,0.82] **
Insurance
Private
Public 0.82 [0.58,1.17] 1.57 [0.99,2.51]
Uninsured 0.62 [0.40,0.95] * 0.72 [0.43,1.21]
Need factors
Perceived mental health
Excellent/very good
Good 0.99 [0.72,1.35] 1.53 [0.94,2.48]
MH Fair/poor 0.64 [0.45,0.92] * 1.93 [1.15,3.25] *
Anxiety
No anxiety
Anxiety 1.53 [1.06,2.22] * 3.52 [2.40,5.15] ***
Perceived physical health
Excellent/very good
Good 0.90 [0.61,1.34] 0.80 [0.46,1.39]
Fair/poor 0.84 [0.54,1.31] 0.59 [0.34,1.01]
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in the introduction combination therapy has been found
to be effective in reducing pain and improving depres-
sive symptoms among older adults [4]. Given the benefi-
cial effects of combination therapy for the elderly, the
study findings suggest that current depression care may
not be optimal for elderly with OA. While this study did
not explore the reasons for lower rates of psychotherapy
among elderly with OA, it can be speculated that elderly
may not receive psychotherapy due to access barriers in
the form of high co-payments related to psychotherapy
[37] or cognitive impairment [36]. Future studies are
needed to explore reasons for low uptake of combin-
ation therapy so that interventions can be tailored to
promote optimal therapy for depression care among
elderly with depression and OA.
In this study combination therapy for depression was
more likely in individuals with anxiety compared to
individuals with depression and without anxiety. It is
well documented that anxiety often co-occurs with
depression in adults with arthritis [1]. In this study,
Table 2 Adjusted odds ratios and 95% confidence intervals from multinomial logistic regression on depression
treatment among individuals with depression and osteoarthritis: medical expenditures panel survey, 2008 and 2010
(Continued)
Pain
No pain at all
Pain 1.17 [0.85,1.60] 0.92 [0.61,1.39]
COPD
No COPD
COPD 1.07 [0.73,1.57] 1.04 [0.69,1.57]
Diabetes
No diabetes
Diabetes 1.64 [1.20,2.25] ** 1.34 [0.90,2.01]
Heart disease
No heart disease
Heart disease 1.49 [1.07,2.09] * 1.32 [0.88,1.99]
Functional disability
No
Yes 0.99 [0.73,1.34] 1.39 [0.94,2.05]
Personal health practice factors
BMI
Under-normal weight
Overweight 1.08 [0.77,1.53] 1.13 [0.71,1.78]
Obese 1.31 [0.92,1.87] 1.51 [1.01,2.25] *
Smoking status
Other
Current smoker 1.15 [0.77,1.72] 1.21 [0.81,1.81]
Exercise
3 times per week
No exercise 0.92 [0.69,1.22] 0.94 [0.65,1.36]
External healthcare environment
Metro
Metro
Rural 1.28 [0.86,1.89] 1.03 [0.67,1.58]
Note: Based on 647 adults, aged 21 years older with self-reported depression and Osteoarthritis who were alive during the calendar year (2008 and 2010).
Asterisks represent significant group differences by type of treatment compared to the reference group based on multinomial logistic regression. The reference
group for the dependent variable in the multinomial logistic regression was “No Depression Treatment”.
AOR: Adjusted odds ratio; CI: Confidence Interval; Sig: significance.
***p< .001;**.001 ≤ p<.01;*.01≤ p<.05.
Agarwal et al. BMC Psychiatry 2013, 13:121 Page 8 of 10
http://www.biomedcentral.com/1471-244X/13/121
nearly 25% of individuals with OA and depression also
reported anxiety disorders. Although treatment for
comorbid depression and anxiety differ by the type of
anxiety disorder, cognitive-behavioral therapy (CBT),
has well-documented efficacy for both depression and
anxiety disorders [38].
The statistically significant association between obes-
ity and combination therapy is also worth noting. Obes-
ity and depression have bi-directional relationship and
they often occur together [39], however, there have been
no studies on combination therapy among individuals
with obesity and depression. In a pilot study it was doc-
umented that individuals who were provided CBT for
depression along with evidence-based behavioral treat-
ment for obesity achieved a clinically significant reduction
in depressive symptoms in 16 weeks [40]. Therefore, it is
plausible that those with obesity and depression may
receive treatments that combine psychotherapy for
depression to achieve better clinical outcomes.
Findings from this study need to be interpreted in the
light of its strengths and limitations. Strengths include a
nationally representative survey, availability of a compre-
hensive list of variables that may be associated with
depression treatment. Furthermore, prescription drug
and psychotherapy information allowed us to categorize
no depression treatment as well as type of depression
treatment. However, there are some limitations. All mea-
sures were self-reported and subject to recall bias. Only
general psychotherapy was measured and distinctions
between types of psychotherapies could not be used,
which may be important in determining appropriate
care. Patient preferences and use of alternative and
complementary medicine for depression treatment were
not included. Therefore, the study could not identify the
reasons for lack of depression treatment among individ-
uals with OA.
Conclusions
Despite these limitations, this study added to the
emerging nascent literature on depression treatment pat-
terns among individuals with chronic physical condi-
tions, specifically OA. It also highlighted many subgroup
differences in likelihood of treatment and type of depres-
sion treatment. Although combination therapy is proven
effective among individuals with OA, some subgroups
such as the elderly and those with chronic illnesses
(example: diabetes and heart disease) did not report
receiving combination therapy. Future research needs to
evaluate barriers to depression care among African
Americans and challenges to combination therapy for
some subgroups of adults with OA. In addition, further
studies need to be conducted as to whether lack of
depression treatment is associated with poor health out-
comes such as functional status among those with OA.
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